PRF Technologies (PRFX) Capital Expenditures (2020 - 2024)
PRF Technologies' (PRFX) quarterly Capital Expenditures came in at -$5000.0 in Q2 2024, up 28.57% on a QoQ basis from -$7000.0 in Q1 2024.
PRF Technologies (PRFX) Capital Expenditures (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Capital Expenditures data on file, last reported at -$5000.0 in Q2 2024.
- Quarterly Capital Expenditures changed N/A year-over-year to -$5000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$3000.0 (changed N/A YoY) and the FY2025 annual result came in at $2000.0, down 84.62% from the prior year.
- Capital Expenditures rose to -$5000.0 in Q2 2024, from -$7000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $240000.0 in Q1 2022 to a low of -$243000.0 in Q2 2022.
- A 5-year average of -$1272.7 and a median of -$6000.0 in 2021 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 1946.15% in 2022, down 8000.0% in 2022.
- Tracing PRFX's Capital Expenditures over 5 years: stood at -$58000.0 in 2020, then soared by 224.14% to $72000.0 in 2021, then sank by 437.5% to -$243000.0 in 2022, then soared by 107.0% to $17000.0 in 2023, then plunged by 129.41% to -$5000.0 in 2024.
- The last three Capital Expenditures figures came in at -$5000.0 (Q2 2024), -$7000.0 (Q1 2024), and $17000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.38 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.87 Bn | 40.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.46 Bn | 30.78 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | - |
| 10 | PRF Technologies | 642,270.82 | -3.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2022 | -243,000.00 |
| Jun 30, 2022 | -243,000.00 |
| Mar 31, 2022 | 240,000.00 |
| Mar 31, 2022 | 240,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Sep 30, 2021 | -6,000.00 |
| Sep 30, 2021 | -6,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Mar 31, 2021 | -13,000.00 |